1. Explosive Global Growth 2. Clinical Need Meets Technological Promise 3. Regional Drivers and Adoption Summary Table Metric Value 2024 Global Market Size USD 1.0 – 1.24 billion 2030 Forecast USD 2.86 billion 2033 Forecast USD 4.3 billion CAGR ~17% U.S. 2023 MCED Market USD 468.5 million Europe 2024 Share ~36% Key Growth Drivers Cancer…
FOR IMMEDIATE RELEASEContact: Jonathan Adam BarashEmail: [email protected]: 516-900-2606Website: www.oncofirmdiagnostics.com OncoFirm Diagnostics Corp. Announces Launch and Opens First Round Funding Opportunities Up to $10 Million Revolutionizing Early Cancer Detection Through Rapid, Antigen-Based Screening Technology Port Washington, New York — April 7 — OncoFirm Diagnostics Corp., a cutting-edge medical diagnostics company, today announced its official launch and…
FOR IMMEDIATE RELEASE Contact: Jonathan Adam Barash Email: [email protected] Phone: 516‑900‑2606 Website: www.oncofirmdiagnostics.com OncoFirm Diagnostics Corp. Announces Launch and Opens First Funding Round Up to $10 Million Advancing Early Cancer Detection Through Rapid, Antigen‑Based Screening Technology Port Washington, New York — April 7 — OncoFirm Diagnostics Corp., an emerging leader in medical diagnostics, today announced…
Investor Disclaimer The information provided by OncoFirm Diagnostics (“Company”) in this document, website, or presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in the Company or any related or affiliated entity. Any such offer or solicitation will be made…
